金雀花碱治疗改善戒烟效果:随机肺癌筛查与多重干预试验
在意大利一项单中心随机对照试验中,869名重度吸烟者随机接受金雀花碱加咨询(470人)或仅咨询(399人)。12个月持续戒烟率干预组为32.1%(151人),对照组为7.3%(29人),调整OR为7.2(95%CI 4.6-11.2)。干预组不良事件更常见。
要点
- 金雀花碱加咨询组12个月持续戒烟率为32.1%,仅咨询组为7.3%。
- 调整OR为7.2(95%CI 4.6-11.2),支持金雀花碱作为戒烟治疗选择。
- 干预组不良事件更常见,最常见为胃肠道症状如腹胀、胃炎和便秘。
核心结论
- 金雀花碱是一种极低成本药物,可作为戒烟的有效治疗选择,并可能改善低剂量CT筛查结局及全因死亡率。
研究设计与样本
- 单中心随机对照试验,2019年7月至2020年3月纳入869名当前重度烟草使用者,随机分为金雀花碱加咨询组(470人)和仅咨询组(399人)。
主要发现
- 12个月随访时,干预组持续戒烟率为32.1%(151人),对照组为7.3%(29人)。
- 持续戒烟的调整OR为7.2(95%CI 4.6-11.2)。
- 干预组自报不良事件更频繁(196人中399起),对照组为(133人中230起),p<0.01。
- 最常见不良事件为胃肠道症状,包括腹胀、胃炎和便秘。
关键数值与推荐
- 主要结局为12个月持续戒烟,通过一氧化碳测量进行生化验证。
- 干预组持续戒烟率32.1%(151人)vs 对照组7.3%(29人),调整OR 7.2(95%CI 4.6-11.2)。
- 不良事件干预组196人中399起 vs 对照组133人中230起,p<0.01。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cytisine, a partial agonist-binding nicotine acetylcholine receptor, is a promising cessation intervention. We conducted a single-center, randomized, controlled trial (RCT) in Italy to assess the efficacy and tolerability of cytisine as a smoking cessation therapy among lung cancer screening participants. METHODS: From July 2019 to March 2020, the Screening and Multiple Intervention on Lung Epidemics RCT enrolled 869 current heavy tobacco users in a low-dose computed tomography screening program, with a randomized comparison of pharmacologic intervention with cytisine plus counseling (N = 470) versus counseling alone (N = 399). The primary outcome was continuous smoking abstinence at 12 months, biochemically verified through carbon monoxide measurement. RESULTS: At the 12-month follow-up, the quit rate was 32.1% (151 participants) in the intervention arm and 7.3% (29 participants) in the control arm. The adjusted OR of continuous abstinence was 7.2 (95% confidence interval: 4.6-11.2). Self-reported adverse events occurred more frequently in the intervention arm (399 events among 196 participants) than in the control arm (230 events among 133 participants, p < 0.01). The most common adverse events were gastrointestinal symptoms, comprising abdominal swelling, gastritis, and constipation. CONCLUSIONS: The efficacy and safety observed in the Screening and Multiple Intervention on Lung Epidemics RCT indicate that cytisine, a very low-cost medication, is a useful treatment option for smoking cessation and a feasible strategy to improve low-dose computed tomography screening outcomes with a potential benefit for all-cause mortality.
引用
- Pastorino U, Ladisa V, Trussardo S, et al. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial. J Thorac Oncol. 2022. PMID: 35908731. doi:10.1016/j.jtho.2022.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。